Mr Kirian Claeyé > ALTIUS > Brussels, Belgium > Lawyer Profile
ALTIUS Offices

HAVENLAAN, 86C B414
AVENUE DU PORT
1000 BRUSSELS
Belgium
- Firm Profile
- Go to...
Mr Kirian Claeyé

Work Department
Intellectual Property
Position
Partner
Career
The latest nominated Partner at ALTIUS (SEP 2023) Kirian specialises in intellectual property and regulatory affairs, with a particular focus on pharmaceuticals and life sciences.
His IP work focuses on complex patent litigation, often involving cross-border issues, parallel trade disputes, and support and advice regarding IP portfolio management. His regulatory work spans the fields of launch and marketing strategies, pricing and reimbursement, tendering, advertising, and lifecycle management.
He regularly speaks at conferences and seminars, is host of ALTIUS’ annual Pharma Law Seminar, and organises ALTIUS’ two-monthly Life Sciences Sessions.
Languages
Kirian is fluent in Dutch, English and French
Memberships
Kirian is a member of the Boalt Hall Alumni Association, (Young) EPLAW, Licensing Executives Society, Belgian American Educational Foundation and the International Association for the Protection of Intellectual Property.
Education
Kirian graduated at the University of Ghent magna cum laude and acquired international experience through postgraduate studies (LL.M) at the University of California, Berkeley School of Law, where he also obtained the Law and Technology Certificate.
- Master in Law (University of Ghent)
- LL.M. (University of California, Berkeley School of Law)
- Law and Technology Certificate (University of California)
Lawyer Rankings
Belgium > EU regulatory: Pharma, medical devices and biotech
The life sciences practice at ALTIUS is ‘always readily available and easily accessible’, representing companies in the pharmaceutical, medical devices, and biotech industries. The team that is ‘very hands on, to the point, communicates fast, and delivers within deadlines’ is led by the experienced litigator Christophe Ronse, Philippe de Jong, and Kirian Claeyé, who is adept at life cycle management and advice on clinical trials.
Belgium > Industry focus: Healthcare and life sciences
(Next Generation Partners)The ‘highly dedicated and knowledgeable‘ team at ALTIUS regularly advises on a broad range of issues in the life sciences sector, with particular strength in handling pricing and reimbursement-related disputes. Christophe Ronse is highly regarded for his expertise in patent litigation, often appearing in local and EU courts in disputes. Philippe de Jong is a name to note for parallel import work, and Kirian Claeyé ‘stands out with his extensive knowledge of the industry‘ and ‘encyclopedic knowledge of Belgian life sciences law‘. The trio co-head the practice.
Belgium > Intellectual property
(Next Generation Partners)The practice at ALTIUS is recognised for its ‘expert staff who work very precisely‘, with expertise covering IP law, unfair competition, and regulatory disputes. The firm is strong in patents, anti-counterfeiting, trademarks, copyrights, design and software piracy. Christophe Ronse leads the team, focusing on patent law and life sciences. Olivier Vrins is ‘easygoing, thorough and the go-to-lawyer for any must-win case concerning trademarks and customs measures‘. Also of note are Philippe de Jong, who focuses on regulatory matters linked to the life sciences and agri-food industries, and Kirian Claeyé, who also focuses on the life sciences industry.
Lawyer Rankings
- Intellectual property Belgium
- Next Generation Partners Belgium > Intellectual property
- Next Generation Partners Belgium > Industry focus: Healthcare and life sciences
- Industry focus: Healthcare and life sciences Belgium
- EU regulatory: Pharma, medical devices and biotech Belgium
Top Tier Firm Rankings
Firm Rankings
- Employment
- EU regulatory: Privacy and data protection
- Industry focus: Food
- Industry focus: Healthcare and life sciences
- Industry focus: IT and telecoms
- Insurance
- Not-for-profit
- Real estate and construction
- Commercial, corporate and M&A
- Competition: Belgian law
- Dispute resolution
- EU regulatory: Financial services
- EU regulatory: Food
- EU regulatory: Pharma, medical devices and biotech
- Insolvency and restructuring
- Private equity
- Banking, finance and capital markets
- Competition: EU and global